A patient diagnosed with depression tells the nurse, "I want to try supplementing my selective serotonin reuptake inhibitor with St John's wort." Which action should the nurse take first?

Reasoning: Choice A reason: St John's wort has significant pharmacodynamic interactions with selective serotonin reuptake inhibitors (SSRIs). Both substances increase synaptic serotonin levels. Combining them significantly elevates the risk of serotonin syndrome, a potentially fatal condition characterized by hyperthermia, rigidity, and autonomic instability. Providing this safety education is the immediate priority. Choice B reason: Suggesting that a patient decrease their prescribed antidepressant dose is outside the legal scope of nursing practice. Dosage adjustments must be managed by the prescribing provider. Furthermore, decreasing the dose without medical supervision could lead to a relapse of depressive symptoms or antidepressant discontinuation syndrome. Choice C reason: While assessing for suicide risk is always important in depression, it is not the most immediate priority when the patient has proposed a specific, dangerous drug interaction. The nurse must first address the acute physiological risk posed by the combination of an SSRI and St John's wort. Choice D reason: Suggesting aromatherapy is an inappropriate primary response to a potential drug interaction. While complementary therapies can be helpful, they do not address the pharmacological danger at hand. The nurse must prioritize evidence-based safety warnings over the suggestion of alternative, less potent therapeutic modalities like aromatherapy.